Ozempic Fatigue That Won’t Go Away

Estimated reading time: 10 minutes

You expected the nausea. You expected to eat less. You didn’t expect to feel like you’re running on half a battery for months.

You’re not lazy. You’re not just “adjusting.” Something real is happening inside your body — and the frustrating part is that it’s probably happening on multiple fronts at once, with nobody tracking any of them.

I’m Dr. Darrell Kilcup. I’ve practiced functional medicine in Phoenix for over 35 years. More and more of my patients are coming in still on their GLP-1 — Ozempic, Wegovy, Mounjaro, Zepbound — and the complaint is the same: “The weight is coming off, but I’m exhausted and it’s not getting better.” Here’s why, and what we actually do about it.

This isn’t a side effect. It’s a signal.

Your prescriber probably told you fatigue can happen in the first few weeks while your body adjusts. And that’s true — some of it is adjustment. But when the fatigue is still there at month three, month four, month six, it’s not your body adjusting. It’s your body telling you something is going wrong that the medication can’t fix and nobody is watching.

A 2026 analysis published in Nature Health looked at over 400,000 Reddit posts from nearly 70,000 people taking semaglutide or tirzepatide. Fatigue was the second most commonly reported symptom — reported by roughly 1 in 6 users — yet in most clinical trials it barely crosses the reporting threshold. In the Wegovy trials, about 11% of patients reported fatigue compared to 5% on placebo. That gap understates the real-world experience, and the reason is that clinical trials aren’t designed to separate “tired from eating less” from “tired because your iron is tanking and your muscle is disappearing.”

The fatigue you’re feeling isn’t one thing. It’s usually several things compounding at once. Here’s what I look for.

You’re in a deeper caloric deficit than you think

GLP-1 medications suppress appetite hard. That’s the mechanism — that’s how they work. But the result is that many patients drop caloric intake by 25–35% without realizing just how steep that is. When your intake drops that far, your body doesn’t just burn fat. It starts rationing energy.

Your metabolic rate slows. Your body temperature drops. Your energy levels follow. This is the same adaptive thermogenesis that happens with any aggressive caloric restriction — but it’s harder to detect on a GLP-1 because you don’t feel hungry. You’re not suffering from cravings or willpower collapse. You’re just… always tired. And because the appetite suppression feels like a feature, not a problem, nobody flags the deficit as too deep.

The SEMALEAN study, which tracked 106 patients on semaglutide 2.4 mg for 12 months using DXA and indirect calorimetry, found that resting energy expenditure declined alongside lean mass — and only started to normalize relative to lean mass between months 7 and 12. Your engine is slowing down while you’re still on the drug. If nobody is measuring it, nobody knows.

You’re losing muscle, and muscle is your engine

This is the part that connects everything. When you’re not eating enough — and especially when you’re not eating enough protein — your body breaks down muscle for fuel. The clinical data is consistent: roughly 25–40% of the weight lost on a GLP-1 can come from lean mass rather than fat. That isn’t a minor rounding error. That’s a quarter to nearly half of your total weight loss coming from the tissue that drives your metabolism.

The same SEMALEAN study showed lean mass dropped about 3 kg in the first seven months. For some patients, especially older adults and postmenopausal women, the loss is more pronounced and the consequences are steeper. A 2025 retrospective cohort study found that semaglutide was associated with accelerated muscle loss and functional decline in older adults with type 2 diabetes — particularly at higher doses and in patients who already had low muscle mass.

Less muscle means a lower resting metabolic rate. A lower metabolic rate means less energy production. Less energy production means you feel exhausted — and the deficit deepens because your body is now burning fewer calories at baseline.

This is the cycle: the drug cuts your intake, you lose muscle because nobody protected it, and the muscle loss makes the fatigue worse. Resistance training and adequate protein are the primary interventions — and they’re the primary things that nobody prescribes alongside the medication.

Your nutrients are draining and nobody is testing for it

When you eat significantly less food for months, you take in significantly less of everything — not just calories. Vitamins. Minerals. The micronutrients your mitochondria need to produce energy.

A 2026 narrative review covering over 480,000 adults on GLP-1 receptor agonists found that vitamin D deficiency was the most common nutritional consequence — 7.5% at 6 months and 13.6% at 12 months — and iron depletion was frequent, with GLP-1 users showing 26% or more reduction in iron markers compared to non-users. That’s on top of the B12 and zinc declines that a separate study in Nutrients documented over 12 months of semaglutide use.

Iron drives oxygen transport. B12 drives nerve function and red blood cell production. Zinc is everywhere — immune function, enzyme activity, wound healing. Vitamin D is tied to muscle function, mood, and immune health. When these levels drop, the result is exactly what you’re feeling: fatigue, brain fog, weakness, flat mood, poor recovery from exercise.

The fix isn’t complicated. Run the labs. Find out what’s low. Replete it properly — not with a generic multivitamin, but with targeted doses based on your actual levels. But someone has to order the labs, and the telehealth GLP-1 model does not do that. A 15-minute check-in and a refill does not catch iron depletion.

Your thyroid may be downregulating

This one is less well-known but increasingly documented. When your body enters a prolonged caloric deficit, it often lowers thyroid output as part of the same energy-conservation response. Free T3 — the active thyroid hormone, the one that actually drives your metabolic rate — tends to drop.

A 2024 study of 290 adults on oral semaglutide found that free T3 decreased significantly during treatment, and the researchers concluded that some of these changes appeared to be independent of weight loss — suggesting a possible direct effect on thyroid regulation that isn’t fully understood yet. Meanwhile, TSH — the marker most doctors check and call “normal” — may shift in the opposite direction, making the standard screening look fine while active thyroid hormone output is actually declining.

For patients already on levothyroxine for hypothyroidism, GLP-1 medications add another layer: semaglutide slows gastric emptying, which can alter levothyroxine absorption and destabilize a dose that’s worked for years.

This is functional medicine territory. A full thyroid panel — not just TSH, but free T3, free T4, reverse T3, and thyroid antibodies — tells a very different story than the single-marker screen most patients get. If nobody runs it, nobody sees the problem.

The nausea is making everything worse

This one is obvious but underappreciated. GLP-1 medications commonly cause nausea — especially during dose escalation. Nausea makes people avoid the foods that are hardest to eat but most important to eat: protein. Meat. Eggs. Fish. Dense, nutrient-rich foods.

When you’re nauseous, you default to bland, low-protein, carbohydrate-heavy foods that are easier to tolerate. Crackers. Toast. Rice. That shift means even the reduced amount you’re eating is nutritionally weaker than it needs to be. Your protein intake drops at the exact moment your body needs it most — to preserve muscle during a deficit. And your micronutrient intake drops even further because the most nutrient-dense foods are the ones you’re avoiding.

So the nausea that seems like a manageable inconvenience is actually feeding the entire depletion cycle. Managing it isn’t just about comfort. It’s about protecting your body composition and your nutrient status.

Here’s what should be happening — and probably isn’t

If you’re taking a GLP-1 and you’re dragging, the question isn’t whether to stop the drug. Most of my patients don’t want to stop, and I don’t tell them to. The question is what needs to happen alongside the drug that currently isn’t.

Protein target, set and tracked. Not a vague “eat more protein” handout — an actual gram target built for your current caloric intake, with a plan to hit it even when you’re nauseous. For most people on a GLP-1, that’s somewhere in the range of 1.2–1.6 grams per kilogram of body weight per day. When your appetite is suppressed, every gram matters.

Resistance training, prescribed. This is the single most protective intervention for muscle during a caloric deficit. It doesn’t have to be extreme — but it has to be consistent, progressive, and deliberate. The data is clear: patients who train during GLP-1 treatment retain significantly more lean mass than those who don’t.

Body-composition tracking. The scale tells you your total weight. It does not tell you whether you’re losing fat or muscle. A body-composition scan — DEXA or InBody — separates fat mass from lean mass and tracks both over time. Without it, you’re guessing.

Micronutrient and metabolic labs. Iron, ferritin, B12, folate, vitamin D, zinc, magnesium, a comprehensive metabolic panel, and a full thyroid panel. These are standard functional medicine labs. They are not standard in the telehealth GLP-1 model. That’s the gap.

Red-light therapy (photobiomodulation). For local patients, PBM supports mitochondrial function, muscle recovery, and cellular energy production. It doesn’t replace any of the above — but as a recovery tool alongside a caloric deficit, it supports the energy systems that are under strain.

This is co-management. You keep your prescription and your prescriber. I manage the things the prescription was never designed to manage — so the weight loss is actually fat loss, your nutrients stay intact, your thyroid is monitored, and you don’t feel terrible for six months while the scale moves in the right direction.

The people who need to pay the most attention

Fatigue on a GLP-1 can affect anyone, but it hits certain populations harder:

Adults over 50. Age-related muscle loss (sarcopenia) is already happening. Add a GLP-1-induced caloric deficit without resistance training and the decline accelerates. The combination of less muscle, lower metabolic rate, and nutrient depletion is more consequential when you have less reserve to start with.

Postmenopausal women. Hormonal changes already reduce muscle-protein synthesis and shift body composition toward fat. A GLP-1 layered on top of that — without monitoring — can deepen the imbalance significantly.

Anyone on the medication for more than 3 months without labs. If you’ve been on Ozempic, Wegovy, Mounjaro, or Zepbound for longer than a few months and nobody has checked your nutrient levels, your thyroid, or your body composition, you’re flying blind. The longer it goes, the deeper the depletions build.

You don’t have to choose between the drug and feeling decent

That’s the core message here. GLP-1 medications are effective tools. They do what they’re designed to do — they suppress appetite and the weight comes off. But they are only one piece. The muscle protection, the nutrition management, the lab monitoring, the training prescription — that’s the rest of the job. And right now, for most patients, nobody is doing it.

If this sounds like your situation — you’re on the medication, the weight is moving, but you’re exhausted, weak, foggy, and nobody can explain why — it’s not the drug failing. It’s the wraparound that was never there.

The drug is doing its job. Someone needs to do the rest.

Dr. Darrell Kilcup, DC, CFMP practices functional medicine in Phoenix, Arizona. If you’re on a GLP-1 and dealing with fatigue that won’t resolve, you can start as a new patient or call (602) 864-0304 to talk it through. Out of state? The lab workup and nutrition coaching can be done remotely — ask about phone and video visits.

Related reading:

• Why You Feel Terrible After Losing Weight on a GLP-1
• Weight Coming Back After Stopping Ozempic
• Hair Loss on Ozempic and Wegovy
• What to Do After Stopping a GLP-1: The Maintenance Plan Nobody Gave You
• Adrenal Fatigue can make you FAT, TIRED, LIBIDO-LESS, CONSTIPATED AND SICK
• Iodine for Hypothyroidism | A Functional Medicine Perspective
• The KEY to Weight Loss